AI assistant
Armata Pharmaceuticals, Inc. — Director's Dealing 2005
Oct 4, 2005
34152_dirs_2005-10-04_65f78caa-63f6-4b7c-af22-dfa3f87e1071.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-10-03
Reporting Person: Poston David J (Acting CFO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.25 | 2009-01-21 | Common Stock (28000) | Direct | |
| Stock Option (right to buy) | $8.56 | 2010-01-20 | Common Stock (7500) | Direct | |
| Stock Option (right to buy) | $6.66 | 2011-01-23 | Common Stock (20000) | Direct | |
| Stock Option (right to buy) | $5.95 | 2011-05-08 | Common Stock (5000) | Direct | |
| Stock Option (right to buy) | $2.57 | 2012-01-22 | Common Stock (32000) | Direct | |
| Stock Option (right to buy) | $0.76 | 2012-08-07 | Common Stock (10000) | Direct | |
| Stock Option (right to buy) | $1.31 | 2014-05-20 | Common Stock (91000) | Direct | |
| Stock Option (right to buy) | $0.91 | 2015-05-26 | Common Stock (27000) | Direct |
Footnotes
F1: Such option is 100% vested and exercisable.
F2: Such option vests and is exercisable 6.25% quarterly, commencing April 22, 2002, with 100% vested and exercisable on April 22, 2006.
F3: Such option vests and is exercisable 6.25% quarterly, commencing November 7, 2002, with 100% vested and exercisable on November 7, 2006.
F4: Such option vests and is exercisable 6.25% quarterly, commencing August 20, 2004, with 100% vested and exercisable on August 20, 2008.
F5: Such option vests and is exercisable 6.25% quarterly, commencing August 26, 2005, with 100% vested and exercisable on August 26, 2009.